1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow InSource Diagnostics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens Urine diagnostic testing as SOC, drug regimen changes per SOC, Urine diagnostic testing with selective PGx testing, drug regimen changes based on PGx test results - Target Drug-related Adverse Events | Phase 4 | Unknown | InSource Diagnostics | 14000 | 2015-12-01 | 2018-02-28 |
Muscle Hypotonia (1)
United States (1)